GlassScriptPhysician profile
Dina K Tack
NPI 1730402025
$5,905.64
in general payments reported to CMS, 2019-2025
57 companies · $1,975 in 2025
The $1,975 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2020: $278 · 2021: $344 · 2022: $527 · 2023: $1,019 · 2024: $1,295 · 2025: $1,975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,152 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,151.50 |
| Education | $136.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $874.63 | 2019-2025 | Opdivo, Opdualag |
| Novartis Pharmaceuticals Corporation | $469.25 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $407.69 | 2019-2025 | Enhertu, Imfinzi |
| Merck Sharp & Dohme LLC | $231.30 | 2020-2025 | Keytruda, Lynparza, Welireg |
| Daiichi Sankyo INC. | $225.83 | 2021-2025 | Enhertu, Datroway, Injectafer |
| Sanofi-Aventis U.S. LLC | $220.46 | 2019-2024 | |
| Gilead Sciences, INC. | $215.78 | 2019-2025 | Trodelvy |
| Janssen Biotech, INC. | $211.63 | 2019-2025 | Rybrevant, Carvykti, Akeega |
| Pfizer INC. | $198.71 | 2023-2025 | |
| Glaxosmithkline, LLC. | $146.76 | 2021-2025 | Zejula, Jemperli, Blenrep |
| Abbvie INC. | $138.83 | 2021-2025 | Lupron Depot |
| Eisai INC. | $136.12 | 2019-2024 | |
| Springworks Therapeutics, INC. | $136.07 | 2024-2025 | Ogsiveo |
| Exelixis INC. | $130.71 | 2025 | Cabometyx |
| Kite Pharma, INC. | $127.95 | 2021-2023 |
Show all 57 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Seagen INC. | $122.17 | 2020-2022 | |
| Amgen INC. | $121.89 | 2019-2023 | Xgeva, Vectibix, Nplate |
| Array Biopharma INC | $111.69 | 2022-2025 | Braftovi, Mektovi, Tukysa |
| Deciphera Pharmaceuticals INC. | $111.57 | 2021-2025 | Romvimza, Qinlock |
| Astellas Pharma US INC | $94.17 | 2019-2025 | Padcev, Vyloy |
| Emd Serono, INC. | $90.93 | 2020-2025 | |
| Genentech USA, INC. | $90.44 | 2019-2024 | Alecensa, Tecentriq |
| Karyopharm Therapeutics INC. | $82.88 | 2020 | |
| Genzyme Corporation | $66.23 | 2021-2024 | |
| Beone Medicines USA, INC. | $64.38 | 2025 | Brukinsa |
| Sobi, INC | $61.88 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $61.69 | 2024-2025 | Onivyde |
| Clovis Oncology, INC. | $58.09 | 2019 | |
| Stemline Therapeutics INC. | $56.57 | 2025 | Orserdu |
| Celgene Corporation | $56.14 | 2023-2024 | Reblozyl, Pomalyst |
| Beigene USA, INC. | $56.03 | 2023 | Brukinsa |
| Servier Pharmaceuticals LLC | $55.22 | 2023-2024 | |
| Tersera Therapeutics LLC | $53.64 | 2024-2025 | Xermelo, Zoladex |
| Regeneron Healthcare Solutions, INC. | $53.04 | 2024 | Libtayo |
| Alexion Pharmaceuticals, INC. | $48.11 | 2024 | Ultomiris |
| Accord Healthcare, INC. | $42.38 | 2024-2025 | |
| Mirati Therapeutics, INC. | $41.61 | 2023 | Krazati |
| Takeda Pharmaceuticals U.S.A., INC. | $37.40 | 2021-2023 | Ninlaro |
| Sirtex Medical INC | $36.19 | 2023 | Sir-Spheres Microspheres |
| Immunocore Limited | $33.73 | 2025 | Kimmtrak |
| Boehringer Ingelheim Pharmaceuticals, INC. | $29.32 | 2024 | Gilotrif |
| Iovance Biotherapeutics, INC. | $24.96 | 2025 | Amtagvi |
| Pharmacyclics LLC, An Abbvie Company | $24.58 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.83 | 2025 | |
| Tactile Systems Technology INC | $21.95 | 2023 | Flexitouch Plus, Entre Plus |
| Octapharma USA, INC. | $21.92 | 2023 | Panzyga |
| Blue Earth Diagnostics | $20.87 | 2025 | Posluma |
| Lilly USA, LLC | $20.47 | 2025 | Verzenio, Jaypirca |
| Myovant Sciences INC. | $19.27 | 2022 | |
| Rigel Pharmaceuticals, INC. | $18.61 | 2022 | |
| Novocure INC. | $17.98 | 2025 | Optune Lua (Novottf-200t) |
| Cti Biopharma Corp. | $17.43 | 2022 | |
| Tempus Ai, INC | $17.22 | 2025 | Xt Cdx |
| Medtronic, INC. | $15.07 | 2021 | |
| Taiho Oncology, INC. | $13.61 | 2024 | |
| Foundation Medicine, INC. | $12.26 | 2022 | |
| Heron Therapeutics, INC. | $7.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dina Tack listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.